Though most patients were released before infection completely resolved, all 10 patients for whom follow-up information was available had documented improvement of the infection.
Whereas a number of previous studies (9– 11) have documented improvements in β-cell function with TZD treatment in people with diabetes, only four studies (12– 15) have investigated this question in people with IFG and/or IGT.
Evaluative analyses of data from the same trial have documented improvements according to six HRQL measures and the six-minute-walk test [ 9], and have shown important differences among results from four major generic HRQL measures [ 10].
In fact, a number of investigators have documented improvements in a variety of intubation related endpoints with the use of VL compared to DL in both human [ 23- 31] and mannequin studies [ 32- 35].
Two pilot randomised controlled trials (RCTs) undertaken by our research team have documented improvements in cardiopulmonary fitness following moderate-intensity endurance exercise training in patients under surveillance for a small AAA.
Whilst there is no apparent consensus regarding the impact of exercise training on resistance vessel function in healthy subjects, the majority of studies performed in subjects with impaired endothelial function have documented improvements.
Finally, cytokeratin staining performed with AE1/AE3 antibodies in a series of lymph nodes from patients with endometrial cancer has documented the improvement of the sensitivity for the detection of metastases compared to HE [ 33].
Since initiation of the NGSP in 1996, the survey has documented a steady improvement in comparability of GHb values among laboratories, both within and between methods (216, 218).
This survey has documented a large potential for improvement in clinical and non-clinical practices aimed at preventing VAP in ICUs.
In addition, bariatric surgery has been shown to substantially improve hypertension, dyslipidaemia and sleep apnoea [ 8] and several reports have documented an improvement of overall survival [ 5] and specific reduction in diabetes-related mortality [ 9].
